Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2258422 | chr13:114158620 | T/C | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2258511 | chr13:114160151 | C/G | 4.56E-12 | 177 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258517 | chr13:114164934 | C/A | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258520 | chr13:114164912 | A/G | 3.99E-12 | 178 | 3.32 | 30.33 | 24.23 | KM Plot |
PCPG | rs2258521 | chr13:114164843 | A/G | 3.6E-12 | 178 | 24.1 | 29.57 | 3.32 | KM Plot |
PCPG | rs2258575 | chr13:114161262 | T/C | 0.000389 | 178 | 24.1 | 29.5 | 3.7 | KM Plot |
PCPG | rs2258578 | chr13:114161464 | G/A | 4.54E-12 | 177 | 24.1 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258579 | chr13:114161465 | G/A | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258628 | chr13:114161819 | G/A | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258629 | chr13:114161875 | C/T | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258633 | chr13:114162033 | T/C | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258678 | chr13:114162722 | A/G | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258680 | chr13:114162635 | A/G | 3.85E-12 | 178 | 3.32 | 29.57 | 24.23 | KM Plot |
PCPG | rs2258682 | chr13:114162594 | A/G | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258683 | chr13:114162579 | C/T | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |